Seroatlas · Human Serome Atlas

NR6A1

Nuclear receptor subfamily 6 group A member 1

Also known as: CT150, GCNF, GCNF1, NR6A1_HUMAN, RTR

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q15406
Gene
NR6A1
Ensembl
ENSG00000148200
Chromosome
9
Canonical length
480 aa
Protein class
Nuclear receptors, Predicted intracellular proteins, Transcription factors
Subcellular location
Nucleoplasm,Centrosome,Cytosol
Quaternary structure
Homodimer

OverviewNCBI Gene

This gene encodes an orphan nuclear receptor which is a member of the nuclear hormone receptor family. Its expression pattern suggests that it may be involved in neurogenesis and germ cell development. The protein can homodimerize and bind DNA, but in vivo targets have not been identified. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Jun 2013]

Canonical amino-acid sequenceUniProt

480 residues, UniProt reviewed canonical sequence.

>Q15406|NR6A1
     1  MERDEPPPSG GGGGGGSAGF LEPPAALPPP PRNGFCQDEL AELDPGTISV SDDRAEQRTC
    61  LICGDRATGL HYGIISCEGC KGFFKRSICN KRVYRCSRDK NCVMSRKQRN RCQYCRLLKC
   121  LQMGMNRKAI REDGMPGGRN KSIGPVQISE EEIERIMSGQ EFEEEANHWS NHGDSDHSSP
   181  GNRASESNQP SPGSTLSSSR SVELNGFMAF REQYMGMSVP PHYQYIPHLF SYSGHSPLLP
   241  QQARSLDPQS YSLIHQLLSA EDLEPLGTPM LIEDGYAVTQ AELFALLCRL ADELLFRQIA
   301  WIKKLPFFCE LSIKDYTCLL SSTWQELILL SSLTVYSKQI FGELADVTAK YSPSDEELHR
   361  FSDEGMEVIE RLIYLYHKFH QLKVSNEEYA CMKAINFLNQ DIRGLTSASQ LEQLNKRYWY
   421  ICQDFTEYKY THQPNRFPDL MMCLPEIRYI AGKMVNVPLE QLPLLFKVVL HSCKTSVGKE

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against NR6A1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.4
Highest tissue expression
21 nTPM

Expression across tissuesHPA

Tissue

  • testis: 21 nTPM
  • thyroid gland: 5 nTPM
  • bone marrow: 4.1 nTPM
  • retina: 2.9 nTPM
  • pancreas: 2.7 nTPM
  • liver: 2.5 nTPM

Single-cell type

  • choroid plexus epithelial cells: 1,018 nCPM
  • sertoli cells: 925 nCPM
  • retinal horizontal cells: 669 nCPM
  • pituitary stem cells: 555 nCPM
  • distal convoluted tubule cells: 474 nCPM
  • neutrophils: 454 nCPM

Immune cell

  • neutrophil: 4.8 nTPM
  • eosinophil: 1.2 nTPM
  • classical monocyte: 0.6 nTPM
  • myeloid DC: 0.6 nTPM
  • intermediate monocyte: 0.5 nTPM
  • non-classical monocyte: 0.3 nTPM

Brain region

  • choroid plexus: 12 nTPM
  • hypothalamus: 9.5 nTPM
  • cerebellum: 6.8 nTPM
  • medulla oblongata: 6.8 nTPM
  • basal ganglia: 6.1 nTPM
  • cerebral cortex: 6 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about NR6A1.

Disease | AllUniProt

Conditions NR6A1 is implicated in, by any mechanism.

Disease | GeneticClinVar

7 pathogenic / likely-pathogenic of 87 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.31
gnomAD pLI
0.98
gnomAD missense Z
1.83
DepMap mean gene effect
0.05
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of NR6A1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads NR6A1 as an antibody target. Whether an autoantibody or antibody against NR6A1 could matter depends on whether native NR6A1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

NR6A1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label NR6A1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/NR6A1. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...